Skip to content
Top Globe News – Lifestyle
Author:
XVIVO Perfusion AB
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO’s Heart Technology
May 18, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 29, 2026
Interim Report January – March 2026
April 29, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 29, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 29, 2026
Conference Call on Interim Report January-March 2026
April 28, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 28, 2026
Annual Report 2025
April 1, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
March 19, 2026